Nevirapine (NVP) Resistance in Women with HIV-1 Subtype C, Compared with Subtypes A and D, after the Administration of Single-Dose NVP

ObjectiveIn the Human Immunodeficiency Virus (HIV) Network for Prevention Trials (HIVNET) 012 trial in Uganda, 6–8 weeks after single-dose nevirapine (SD-NVP), NVP resistance mutations were detected at a higher rate in women with HIV-1 subtype D than in women with subtype A. Here, we evaluate the ra...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of infectious diseases 2005-07, Vol.192 (1), p.30-36
Hauptverfasser:	Eshleman, Susan H., Hoover, Donald R., Chen, Shu, Hudelson, Sarah E., Guay, Laura A., Mwatha, Anthony, Fiscus, Susan A., Mmiro, Francis, Musoke, Philippa, Jackson, J. Brooks, Kumwenda, Newton, Taha, Taha
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult AIDS Anti-HIV Agents - administration & dosage Anti-HIV Agents - pharmacology Dosage Drug Administration Schedule Drug Resistance, Viral Experimentation Female Gender equality Genetic mutation Genotype Health care administration HIV HIV 1 HIV Infections - prevention & control HIV-1 - classification HIV-1 - drug effects HIV-1 - genetics HIV/AIDS Human immunodeficiency virus 1 Humans Infectious Disease Transmission, Vertical - prevention & control Nevirapine - administration & dosage Nevirapine - pharmacology Pregnancy Viral load Viral Proteins - genetics Women
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!